Evidence map›Paper›PMID 25945714›Full record

ArticleActa crystallographica. Section F, Structural biology communications2015

Structure of an ADP-ribosylation factor, ARF1, from Entamoeba histolytica bound to Mg(2+)-GDP.

Dmitry A Serbzhinskiy, Matthew C Clifton, Banumathi Sankaran, Bart L Staker, Thomas E Edwards, Peter J Myler

Abstract read
In one paragraph

Article in Acta crystallographica. Section F, Structural biology communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Crystal structure of Plasmodium vivax macrophage migration inhibitory factor.Acta crystallographica. Section F, Structural biology communications · 2026
    Article
  2. Article
  3. Article
  4. Crystal structure of carbon-nitrogen hydrolase from Helicobacter pylori G27.Acta crystallographica. Section F, Structural biology communications · 2026
    Article
  5. Crystal structure of a short-chain dehydrogenase from Brucella ovis with apo and coenzyme NADActa crystallographica. Section F, Structural biology communications · 2025
    Article
  6. Crystal structures of the putative endoribonuclease L-PSP from Entamoeba histolytica.Acta crystallographica. Section F, Structural biology communications · 2025
    Article
  7. The crystal structures of apo and tryptophan-bound tryptophanyl-tRNA synthetase from Neisseria gonorrhoeae.Acta crystallographica. Section F, Structural biology communications · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Crystal structure of dihydroorotate dehydrogenase from Helicobacter pylori with bound flavin mononucleotide.Acta crystallographica. Section F, Structural biology communications · 2025
    Article
  12. Co-crystal structure of Helicobacter pylori biotin protein ligase with biotinyl-5-ATP.Acta crystallographica. Section F, Structural biology communications · 2025
    Article
  13. Article
  14. Crystal structure of glutamyl-tRNA synthetase from Helicobacter pylori.Acta crystallographica. Section F, Structural biology communications · 2024
    Article
  15. Structures of Trichomonas vaginalis macrophage migratory inhibitory factor.Acta crystallographica. Section F, Structural biology communications · 2024
    Article
  16. Article
  17. Article
  18. Ternary structure of Plasmodium vivaxN-myristoyltransferase with myristoyl-CoA and inhibitor IMP-0001173.Acta crystallographica. Section F, Structural biology communications · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dmitry A SerbzhinskiySeattle Structural Genomics Center for Infectious Disease (SSGCID), USA.
Matthew C CliftonSeattle Structural Genomics Center for Infectious Disease (SSGCID), USA.
Banumathi SankaranBerkeley Center for Structural Biology, Lawrence Berkeley National Laboratory, 1 Cyclotron Rd, Berkeley, CA 94720, USA.
Bart L StakerSeattle Structural Genomics Center for Infectious Disease (SSGCID), USA.
Thomas E EdwardsSeattle Structural Genomics Center for Infectious Disease (SSGCID), USA.
Peter J MylerSeattle Structural Genomics Center for Infectious Disease (SSGCID), USA.

Funding

NIAID NIH HHS HHSN272201200025CPHS HHS HHSN272201200025C
6 · The paper itself

Abstract

Entamoeba histolytica is the etiological agent of amebiasis, a diarrheal disease which causes amoebic liver abscesses and amoebic colitis. Approximately 50 million people are infected worldwide with E. histolytica. With only 10% of infected people developing symptomatic amebiasis, there are still an estimated 100,000 deaths each year. Because of the emergence of resistant strains of the parasite, it is necessary to find a treatment which would be a proper response to this challenge. ADP-ribosylation factor (ARF) is a member of the ARF family of GTP-binding proteins. These proteins are ubiquitous in eukaryotic cells; they generally associate with cell membranes and regulate vesicular traffic and intracellular signalling. The crystal structure of ARF1 from E. histolytica has been determined bound to magnesium and GDP at 1.8 Å resolution. Comparison with other structures of eukaryotic ARF proteins shows a highly conserved structure and supports the interswitch toggle mechanism of communicating the conformational state to partner proteins.

Indexed as

ADP-Ribosylation Factor 1ADP-Ribosylation FactorsAmino Acid SequenceCrystallizationEntamoeba histolyticaGuanosine DiphosphateHumansMagnesiumMolecular Sequence DataProtein BindingProtein Structure, SecondaryADP-Ribosylation Factor 1ADP-Ribosylation FactorsGuanosine DiphosphateMagnesiumARFA1GDP-ribosylation factorSeattle Structural Genomics Center for Infectious Diseasesignaling proteinsmall GTPaseSSGCIDstructural genomics

Identifiers

PMID25945714
PMCPMC4427170

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.